发明授权
- 专利标题: Pyrazolopyrimidine compound and a process for preparing the same
- 专利标题(中): 吡唑并嘧啶化合物及其制备方法
-
申请号: US10542081申请日: 2004-01-23
-
公开(公告)号: US07384952B2公开(公告)日: 2008-06-10
- 发明人: Iwao Takamuro , Yasuo Sekine , Yasunori Tsuboi , Kouji Nogi , Hiroyuki Taniguchi
- 申请人: Iwao Takamuro , Yasuo Sekine , Yasunori Tsuboi , Kouji Nogi , Hiroyuki Taniguchi
- 申请人地址: JP Osaka-shi
- 专利权人: Mitsubishi Tanabe Pharma Corporation
- 当前专利权人: Mitsubishi Tanabe Pharma Corporation
- 当前专利权人地址: JP Osaka-shi
- 代理机构: Birch, Stewart, Kolasch & Birch, LLP
- 优先权: JP2003-016770 20030124; JP2003-205341 20030801; JP2003-385399 20031114
- 国际申请: PCT/JP2004/000617 WO 20040123
- 国际公布: WO2004/064721 WO 20040805
- 主分类号: C07D487/04
- IPC分类号: C07D487/04 ; C07D519/00 ; A61K31/519
摘要:
The present invention provides a novel pyrazolopyrimidine compound of the formula [I]: wherein R′ is (A) a substituted aryl group, (B) an optionally substituted nitrogen-containing aliphatic heteromonocyclic group, (C) a substituted cyclo-lower alkyl group, (D) an optionally substituted amino group, or (E) a substituted heteroaryl group, R2 is (a) an optionally substituted heteroaryl group or (b) an optionally substituted aryl group, Y is a single bond, a lower alkylene group or a lower alkenylene group, Z is a group of the formula: —CO—, —CH2-, —SO2- or a group of the formula [II]: Q is a lower alkylene group, and q is an integer of 0 or 1 or a pharmaceutically acceptable sait thereof, which has a small conductance potassium channel (SK channel) blocking activity and is useful as a medicament and a process for preparing the same
公开/授权文献
信息查询